HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple-blind, placebo-controlled, clinical trial.

AbstractAIMS:
To assess the efficacy and safety of bemiparin in the treatment of chronic diabetic foot ulcers.
METHODS:
A triple-blind, parallel, randomized, placebo-controlled trial. Patients aged > 18 years, [corrected] with diabetes for at least 3 years, and with a foot ulcer persisting for > 3 months were selected from 39 Spanish centres. Bemiparin 3500 IU/day for 10 days, followed by 2500 IU/day for up to 3 months plus standard care for ulcers, was compared with placebo plus standard care for ulcers for 3 months. The primary efficacy end-point was ulcer improvement, defined as an objective decrease in ulcer area of >or= 50%, measured by digital photography and ImageJ software, and/or any decrease in Wagner's ulcer grade at 3 months.
RESULTS:
Ulcer improvement rates were 70.3% (26 of 37 patients) in the bemiparin group and 45.5% (15 of 33 patients) in the placebo group [absolute difference 24.8; 95% confidence interval (CI) 2.3, 47.3; P = 0.035] (number needed to treat 4; 95% CI 2, 43). Complete healing rates at 3 months were similar in both groups (35.1% vs. 33.3%; P = 0.874), as were the number of adverse events.
CONCLUSIONS:
Bemiparin is more effective than placebo in the management of diabetic foot ulcers and has few side-effects.
AuthorsM Rullan, L Cerdà, G Frontera, L Masmiquel, J Llobera
JournalDiabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 25 Issue 9 Pg. 1090-5 (Sep 2008) ISSN: 1464-5491 [Electronic] England
PMID19183313 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • bemiparin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Diabetic Foot (drug therapy)
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Heparin, Low-Molecular-Weight (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Statistics as Topic
  • Treatment Outcome
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: